Efficacy of random-start controlled ovarian stimulation in cancer patients

Journal of Korean Medical Science
Jee Hyun KimSeok Hyun Kim

Abstract

This study aimed to evaluate the efficacy of random-start controlled ovarian stimulation (COS) in cancer patients for emergency fertility preservation. In this retrospective comparative study, 22 patients diagnosed with cancer and 44 infertile women undergoing conventional in vitro fertilization (IVF) were included. In cancer patients, ovarian stimulation was started on the day of referral, irrespective of their menstrual cycle date. The control group was selected by age matching among women undergoing conventional IVF. COS outcomes were compared between groups. The number of total and mature oocytes retrieved and the oocyte maturity rate were higher in the random-start group than in the conventional-start group. However, duration of ovarian stimulation was longer in the random-start group (11.4 vs. 10.3 days, P = 0.004). The addition of letrozole to lower the estradiol level during COS did not adversely affect total oocytes retrieved. However, oocyte maturity rate was lower in cycles with letrozole than in cycles without letrozole (71.6% vs. 58.2%, P = 0.019). Our study confirms the feasibility and effectiveness of random-start COS in cancer patients.

References

Oct 1, 1990·Fertility and Sterility·T D PacheB C Fauser
May 1, 1983·The Journal of Clinical Endocrinology and Metabolism·K P McNattyE V van Hall
May 16, 2003·Biology of Reproduction·Angela R BaerwaldRoger A Pierson
Jul 10, 2003·Fertility and Sterility·Angela R BaerwaldRoger A Pierson
Aug 3, 2006·The Journal of Clinical Endocrinology and Metabolism·Kutluk OktayHeejung Bang
May 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amr A AzimKutluk Oktay
Oct 16, 2008·Reproductive Biomedicine Online·Ezgi DemirtasSeang Lin Tan
May 5, 2010·Reproductive Sciences·Paulo Homem de Mello BianchiEdmund Chada Baracat
May 11, 2010·Journal of Assisted Reproduction and Genetics·Giuliano M BedoschiPaula Andrea Navarro
Apr 1, 2011·Human Reproduction Update·P HumaidanUNKNOWN Copenhagen GnRH Agonist Triggering Workshop Group
Nov 10, 2011·Human Reproduction Update·Angela R BaerwaldRoger A Pierson
May 3, 2013·Fertility and Sterility·Hakan Cakmak, Mitchell P Rosen
Aug 31, 2013·Fertility and Sterility·Hakan CakmakMitchell P Rosen

❮ Previous
Next ❯

Citations

Jul 2, 2015·Journal of Assisted Reproduction and Genetics·M ShapiraD Meirow
May 6, 2016·Journal of Assisted Reproduction and Genetics·C E BootsE S Jungheim
Apr 1, 2017·Current Opinion in Obstetrics & Gynecology·Alberto VaiarelliFilippo M Ubaldi
Jan 30, 2018·Clinical and Experimental Reproductive Medicine·Hoon KimSeok Hyun Kim
Feb 14, 2019·Acta Obstetricia Et Gynecologica Scandinavica·Stine Gry KristensenClaus Yding Andersen
Aug 8, 2019·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Se Jeong KimSeok Hyun Kim
Aug 16, 2017·Journal of Oncology Practice·Nigel Pereira, Glenn L Schattman
Mar 11, 2020·Frontiers in Endocrinology·Ernesto BoschPeter Humaidan
Jun 15, 2019·Science China. Life Sciences·Dongming LiuJie Qiao
Jan 18, 2018·Fertility and Sterility·Molly B MoravekMary Ellen Pavone
Apr 2, 2021·Frontiers in Endocrinology·Sophie FischerSusanna Röblitz
Oct 4, 2020·Journal of Gynecology Obstetrics and Human Reproduction·Tiffany BrunSolène Duros
Aug 13, 2021·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Gulnaz SahinErol Tavmergen

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.